Navigation Links
Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
Date:12/1/2009

PLEASANTON, Calif., Dec. 1 /PRNewswire/ -- The new position of Executive Vice President, Commercial Affairs at Microchip Biotechnologies, Inc. has been taken up by Howard Goldstein, a biotech lab systems executive with more than 30 years of experience creating and managing life science product organizations. Mr. Goldstein will direct Microchip Biotechnologies' marketing, business development, sales and customer service operations as the company makes the transition from product development to full commercial operations.

"Howard adds directly relevant strategic, operational, and commercial experience to our executive profile," said Stevan Jovanovich, President/CEO of Microchip Biotechnologies. "His leadership and expertise will be keys to the realization of our commercial growth objectives."

Prior to joining Microchip Biotechnologies, Mr. Goldstein first served as Chief Executive Officer and then Chief Commercial Officer of Arcxis Biotechnologies, and was Managing Partner of Practical Marketing and Sales, a biotech business consultancy. He has been responsible for building and directing marketing, engineering, and sales teams that have created more than 10 key product categories in the research marketplace. Mr. Goldstein received his MBA degree in Organizational Development from Temple University, Philadelphia, PA and an M.Sc. degree in Biochemistry from the University of Dayton, Dayton OH.

About Microchip Biotechnologies, Inc.

Microchip Biotechnologies, Inc. (MBI), headquartered in Pleasanton, CA is a venture-backed, privately held company that produces automated sample processing systems for life sciences, applied sciences, and healthcare diagnostics markets. The company's products are based on the Apollo fluidics technology platform, which integrates advanced fluidics and analytical capabilities to produce automated sample-to-answer systems for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, and molecular diagnostics applications. The company's first product, the Apollo 100 System, automates sample processing for Sanger cycle sequencing and dramatically reduces process requirements for expensive sequencing reagents. For additional information about MBI, visit http://www.microchipbiotech.com.


Contact: Howard D. Goldstein
Microchip Biotechnologies Inc.
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94568
(925) 701-3481
howard.goldstein@microchipbiotech.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Microchip Biotechnologies, Inc.


'/>"/>
SOURCE Microchip Biotechnologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
2. PFC Pharma Joins DATATRAKs CRO Connect Program
3. William Cork Joins Fenwal as Chief Technology Officer
4. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
5. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
6. American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento
7. Marsha Fanucci Joins Ironwood Board of Directors
8. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
9. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
10. Dilon Diagnostics Joins Forces With Philips for Womens Health Solutions
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 Dr. Vivek Ahuja , ... Ste phen Schmidt ... provider of cloud-based software solutions for life sciences, today announced key ... a wealth of insight to a growing business.  This will bolster ... George Phillips joined ArisGlobal in the position of Vice ...
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... TURIN, Italy , April 27, 2016 ... MR-guided linear accelerator (MR-linac) platform will be the focal ... annual meeting of the European Society for Radiotherapy & ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and ... a physician to clearly see the patient,s anatomy in ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed ... an upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show ... Grassland Dairy Products, located in Greenwood, Wisconsin applies product research and development and ...
(Date:4/29/2016)... ... 2016 , ... Nike Softball Camp at the College of Brockport in New ... girls aged 10-18. All facets of the game will be covered; hitting, fielding, base-running, ... one of the finest softball facilities in the region. The outstanding professional college staff ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coalition Duchenne, ... dystrophy, and funding for Duchenne research, participated in the April 25 U.S. Food ... novel Duchenne drug eteplirsen. The meeting at the Marriott Conference Center in Hyattsville, ...
(Date:4/29/2016)... ... April 29, 2016 , ... Pro3rd Grunge is a package of 30 grunge-themed ... to introduce people, characters, and locations without having to set a single keyframe. Choose ... many more design components. Simply select a preset and drag it into the ...
Breaking Medicine News(10 mins):